# Obesity-associated gut microbiome influences diet-induced metabolic and cognitive outcomes in older adults

**Authors:** Cole Patoine, Julia Sheffler, Trinity Sims, Viviana Gutierrez, Gwoncheol Park, Moses Mayonu, Bo Wang, Ravinder Nagpal

PMC · DOI: 10.1080/29933935.2025.2605879 · Gut Microbes Reports · 2025-12-25

## TL;DR

This study explores how obesity and gut microbes affect cognitive and metabolic outcomes in older adults following different diets.

## Contribution

The study identifies a gut-muscle-brain axis as a modifiable target for improving cognitive health in aging populations.

## Key findings

- Obese individuals showed lower gut microbial diversity and poorer cognitive function.
- Fat loss in obese participants correlated with improved memory and cognitive flexibility.
- Changes in gut and plasma metabolites were linked to cognitive and body composition outcomes.

## Abstract

Obesity in older adults is a known risk factor for Alzheimer’s disease and related dementias, potentially driven by metabolic dysfunction, inflammation and gut dysbiosis. The gut-brain axis, influenced by diet and the gut microbiome, is increasingly recognized as a contributor to neurodegeneration. In this sub-analysis of a 10-week randomized dietary education intervention (NCT06121986), we examined how obesity modulates gut microbiome, metabolome, and cognitive responses in 31 adults aged 55–85, with or without mild cognitive impairment. Participants received education on either a Mediterranean Diet or a Modified Mediterranean-Ketogenic Diet. Analyses were stratified by baseline obesity (BMI ≥30 kg/m²). Individuals with obesity exhibited lower microbial alpha-diversity, higher Bacteroides, and lower Akkermansia and Christensenellaceae_R-7_group, along with poorer memory and executive function. Only in the obese group did fat loss correlate with improvements in episodic memory and cognitive flexibility. In contrast, increased fat mass was associated with improved memory in non-obese participants. Gains in skeletal muscle mass predicted cognitive improvement in adults aged ≥73. Changes in gut (acetate, propionate, lactate) and plasma (acetate, pyruvate, citric acid) metabolites were linked to cognitive and body composition outcomes. These exploratory findings highlight the gut-muscle-brain axis as a modifiable target to enhance cognitive health in aging populations.

## Linked entities

- **Chemicals:** acetate (PubChem CID 175), propionate (PubChem CID 104745), lactate (PubChem CID 61503), pyruvate (PubChem CID 107735), citric acid (PubChem CID 311)
- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Diseases:** dementias (MESH:D003704), metabolic dysfunction (MESH:D008659), fat loss (MESH:D004620), inflammation (MESH:D007249), Alzheimer's disease (MESH:D000544), Obesity (MESH:D009765), neurodegeneration (MESH:D019636), cognitive impairment (MESH:D003072), gut dysbiosis (MESH:D064806)
- **Chemicals:** acetate (MESH:D000085), pyruvate (MESH:D019289), lactate (MESH:D019344), citric acid (MESH:D019343), propionate (MESH:D011422)
- **Species:** Bacteroides (genus) [taxon 816], gut metagenome (species) [taxon 749906]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938881/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938881/full.md

## References

107 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938881/full.md

---
Source: https://tomesphere.com/paper/PMC12938881